chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stomach ache; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Feb2021 at 08:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 22Feb2021 at 22:00, the patient experienced stomach ache and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stomach ache and vomiting was recovering at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Dermatographia all over my body. Rashes welts started on chest and ears. Moved to legs stomach back. Everywhere. Taking antihistamines multiple times a day to keep itching away. Red welts still appearing. Itching still happening when not taking antihistamine.
3 days receiving the 1st shot, I began experiencing dizziness. For the next few days, it progressively got worse and eventually led to me not being able to drive. After over 7 weeks, although it's gotten the better, the dizziness still persists as spasm like episodes throughout the day.
Pt described that she experienced weakness in her arms, migraines, high blood pressure, severe nerve pain, and spasms in hand.
Site of injection red and painful, warm outside of arm by deltoid and around inside of arm. Erythema with induration at point of injection. Erythema encompasses more than 75% circumference to upper arm.
Information has been received for the pregnancy registry for GARDASIL from a physician concerning a 20 year old female patient, who in October 2009, "6 months ago", was vaccinated with the first dose of GARDASIL (route and lot number not provided). A couple of weeks after 1st dose, the patient got pregnant. The patient also developed Bell's Palsy after receiving the first dose but had a miscarriage sometime after developing Bell's Palsy. It was reported that the Bell's Palsy was getting better at the time of reporting. The patient's outcome regarding the miscarriage was unknown. The patient sought unspecified medical attention via office visit. Upon internal review, miscarriage was considered to be an other important medical event. Additional information has been requested.
Noticed another significant improvement in my stamina and alertness; In recent weeks my need for insulin as been cut in half and still going down further; I suffer from Chronic Fatigue, so it is unusual for me to feel exhausted after certain injections. The exhaustion lasted two days/suffering for two days with exhaustion from the vaccine; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Noticed another significant improvement in my stamina and alertness), DECREASED INSULIN REQUIREMENT (In recent weeks my need for insulin as been cut in half and still going down further) and FATIGUE (I suffer from Chronic Fatigue, so it is unusual for me to feel exhausted after certain injections. The exhaustion lasted two days/suffering for two days with exhaustion from the vaccine) in a 70-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included Bedridden and Gait disturbance. Concurrent medical conditions included Chronic fatigue syndrome (Chronic fatigue immune dysfuction syndrome), Cerebral disorder (fogged brain, searching for words and difficulty with simple math), Memory loss and Diabetic (Patient was on insulin and in recent weeks his need for insulin has been cut in half and still going down further.). Concomitant products included INSULIN for Diabetic.    On 26-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 27-Sep-2023, the patient experienced DECREASED INSULIN REQUIREMENT (In recent weeks my need for insulin as been cut in half and still going down further) and FATIGUE (I suffer from Chronic Fatigue, so it is unusual for me to feel exhausted after certain injections. The exhaustion lasted two days/suffering for two days with exhaustion from the vaccine). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Noticed another significant improvement in my stamina and alertness). On 28-Sep-2023, DECREASED INSULIN REQUIREMENT (In recent weeks my need for insulin as been cut in half and still going down further) and FATIGUE (I suffer from Chronic Fatigue, so it is unusual for me to feel exhausted after certain injections. The exhaustion lasted two days/suffering for two days with exhaustion from the vaccine) had resolved. At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Noticed another significant improvement in my stamina and alertness) outcome was unknown.            Treatment medications was not reported.  After Spikevax administration on 26-Sep-2023, the patient had noticed another significant improvement in stamina and alertness. The patient felt it was important for research in the area of vaccine and the effect on chronic fatigue dysfunction syndrome.   This case was linked to MOD-2022-583908 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Nov-2023: Significant follow-up received on 13-NOV-2023: Reporter details, Patient details, Medical history, Route of Administration, Concomitant medication, Events and narrative were updated.
Nine days after receiving MMR and Varicella, she developed a macular rash at the Varicella injection site, then on her neck and torso.
Redness and itching (L) deltoid. Ibuprofen and BENADRYL.
This spontaneous report as received from a medical assistant refers to a 6-year-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 11-APR-2016, the patient was vaccinated with an incorrectly stored dose of PROQUAD (therapy type: rHA, lot # L031601, an expiration date 18-FEB-2017, dose, dose number, anatomical location and route of administration were not provided). It was reported that the refrigerator was out of range. This is one of several reports received from the same reporter. Additional information is not expected as all data was already obtained.
Moderate swelling with erthema from shoulder to just proximal elbow, mild swelling of whole arm.  Dx: Dermatitis fx: CARAITIN/MOTRIN.
Pt recv vax on 5/5/99; on 5/6/99 pt exp red spots all over body w/ itching
Woke up the morning after receiving vaccine with some queasiness, and stomach gurgling.  Still having the queasiness and gurgling. No diarrhea or vomiting.
serious dizziness upon standing from lying down; tiredness; turning in bed; both times feeling generally unwell; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 72 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 23Mar2021 (Lot number: ER2613) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication included: HUMIRA. Vaccination history included: BNT162B2 (Dose 1, Arm left, 04:15 PM, Lot number: EN6202), administration date: 26Feb2021, for COVID-19 Immunization, reactions: "vertigo", "lethargy", "tiredness". The following information was reported: DIZZINESS POSTURAL (non-serious), outcome "not recovered", described as "serious dizziness upon standing from lying down"; FATIGUE (non-serious), outcome "not recovered", described as "tiredness"; RESTLESSNESS (non-serious), outcome "not recovered", described as "turning in bed"; MALAISE (non-serious), outcome "not recovered", described as "both times feeling generally unwell". The events "serious dizziness upon standing from lying down", "tiredness", "turning in bed" and "both times feeling generally unwell" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness postural, fatigue, restlessness, malaise. Additional information: Patient had not had COVID-19 prior to vaccination. She had no known allergies.  No follow-up attempts are possible. No further information is expected.
I would just get irregular skipped heart beats, I decided to see a doctor 6 month after because it wouldn't go away, I seen Dr.  August 25, 2021. She recommended to have EKG Thyroid test, referral to Cardiology and I was monitored for 1 week straight and they notice PBC, I also got a stress test that came back normal.
Headache; A few heart palpitations- this was sporadic and did not last long; numbness of left side and marked numbness of left thumb and up left forearm; Strong skin tingling all over body; Knee joints  felt like they were on fire; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 51-years-old and non-pregnant at the time of vaccination) as a DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included estradiol and lisinopril. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Mar2021, the patient reported that she experienced a headache which started immediately after the first shot. In Mar2021, the patient experienced strong skin tingling all over the body, no fever, her knee joints felt like they were on fire, fatigue, headache, a few heart palpitations that were sporadic and did not last long, numbness of left side and marked numbness of left thumb and up left forearm. The patient reported that all the symptoms were mostly gone within 3 days. The patient did not receive any treatment for the events. The outcome of the events was resolved in Mar2021.  No follow-up attempts are needed. No further information was expected.
ARM WAS SORE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  On MAR-2021, the subject experienced arm was sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of arm was sore was not reported. This report was non-serious.
Severe chills- could not get body temperature normal until late nighttime; headache; backache; headache; nausea; digestive discomfort; unable to eat for 2 days.
Chills beginning at 7 hours after vaccine, 103 degree fever as taken at 11 hours after, body aches, fatigue; normal temp at 17 hours after but fatigue, headache;  low grade temperature returned at 24 hours (99.8); arm pain and fatigue still present at 48+ hours
Severe flu-like symptoms (fever; severe aches in joints) Tinnitus in left ear
Left leg swollen from thigh to ankle, pain with weight bearing, ecchymosis and petechiae
Began to have a rash on his chest on 07/29/20.  Now, 2 week , mother states the rash is on his face, shoulders, chest, and back.  No pain or redness @ either vaccination injection sites.  DH asked mother to refer to primary provider for evaluation of the rash.
This spontaneous report was received from a physician via company representative concerning a to an 11 year old female patient. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. The patient did not had any drug reactions or allergies. On 09-JUN-2017, the patient was vaccinated with  a dose of GARDASIL 9 (route, dose, dose number, frequency, anatomical location, lot # and expiration date were unknown) for prevention of human papillomavirus infection (HPV) and also was vaccinated with a dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (TDAP) (route, dose, frequency, anatomical location, indication, lot # and expiration date were unknown). Subsequently, on the same date, reported as "shortly after" receiving the vaccines the patient passed out. It was unknown how long did the patient was unconscious, or if any specific treatment was given to her. No laboratory diagnostic tests were performed. At the time of reporting, the outcome of syncope was unknown. The physician stated that it was not known whether the patient pass out due to the GARDASIL 9 or the diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (TDAP) or both. There was no product quality involved. Additional information has been requested.
Fever: 100.5 (rectal)- documented in ER/clinic. 104 (as per patient's parent). Treated with TYLENOL/ibuprofen.
16OCT94-4pm-t 103.5ax (pt hot since 7-8am),gave cool bath,alcohol rub didn't dec t; loss of appetite,4PM-sz(eyes back,foamed @ mouth,cyanotic,stiff/jerked)didn't responsd 30 mins;to hosp;tx w/ apap/ATB;17OCT-t inc,to hosp,tx w/apap/ATB
1. Tinnitus increased dramatically about 12 hours after booster, enough to prevent sleep. Previously, I had increased tinnitus after the second Pfizer shot, but that came on about 10 days after that shot and increased gradually, then subsided. This time, though, the tinnitus increased quickly and strongly soon after the shot. 2. Soreness in injection site. Arm feels tender.
This study case was received from the investigator on 24 May 2013. A 25-year-old male subject received the an injection of ACAM2000 (lot number, route and site of administration not reported) on 13 March 2013 and the following vaccinations on 12 March 2013: TYPHIM (lot number, route and site of administration not reported) and Anthrax (manufacturer, lot number, route and site of administration not reported). The subject was diagnosed with unspecified disease of pericardium on 26 March 2013 and other and unspecified acute myocarditis on 28 March 2013. Relevant laboratory data included abnormal Troponin I at 00.89 and an abnormal ECG on 26 March 2013, a normal echocardiogram on 27 March 2013 and an abnormal MRI (heart) on 28 March 2013. Treatments were not reported. The subject had no past medical history. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
A health care professional reported that a 44 year old male pt received a dose of Flumist on 10/16/03 and experienced muscle aches, fever and chest congestion. The pt experienced muscle aches (myagia) on 10/17/03, fever on 10/21/03 and chest congestion on 10/26/03. The pt was treated with erythromycin, prednisone and Mucinex. The pt has recovered. No additional info was available at the time of this report.
Patient experienced fever (100.3) and extreme flu-like symptoms (pain in joints, nausea, fatigue).  Slept for 18 hours to recover, taking acetaminophen every 6 hours.  Patient felt recovered 1/13/2019 at 6:00 AM. Because of ITP, patient has had splenectomy, which increases the risk of becoming sick or getting serious infections.  It is for that reason that the vaccination was ordered. Patient has experienced similar adverse events after Influenza vaccine.
Upon waking up at 6:30Am passed out (fainted) and followed by tachycardia. One hour later vomiting. Stayed home from school-kept hydrated, gave ATARAX 10mg, gave Ondansetron 4 mg.
marks and rash on neck lasting over 2 week; moving to arm, initially diagnosed with Shingles; Dermatologist unable to determine exactly what is wrong
Onset of pruritic and painful papular lesions on hands and fingers 12 days post vaccination followed 2 days later by the appearance of lesions on rt elbow. Felt well at time of immunization. No other symptoms. Symptoms: Lesions, papule, Pruritus, Tenderness.
PATIENT REPORTED RED, ITCHY RASH SPREAD OUT ON HIS BACK. NO WEEPING AND PAIN.
I received the vaccine around 3:45pm on Friday. Saturday night I went to bed and everything seemed fine. At 2am I woke up because my right hand was completely numb. I tried to "wake it up" by moving my wrist and my fingers. It took quite a while to eventually get the "pins and needles" feeling. That feeling lasted close to 30 minutes. My hand was uncomfortable the rest of the night. The next morning, Sunday, my right hand still had slight numbness around my thumb. The entire day my thumb was numb and I had the tingly feeling as I had experienced that night. All day today, Monday, I still have numbness in my right hand, mostly in and around my thumb. My grip isn't as strong as it usually is and holding a pen to write is slightly difficult.
Day of DTaP, arm red and slight swelling. By AM has ? after shots given, 10cmx10cm red, raised, hot area around injection site. 4cm slightly ecchymotic; 2cm blister over injection site. Rechecked in 24 hours; augmentin restarted. PM 8/20/03, area slightly better with cellulitis.
Pt experienced flushing, malaise, weakness with the onset of these symptoms 1/2/ hour post vax.
ACUTE DVT OF LEFT PERONEAL VEIN HYPOXIA 10/28/2022 -- RECURRENCE OF SAME SYMPTOMS
Vertigo and dizziness the weeks following second dose, acute sialadenitis (resolved with Augmentin), tingling, ear infection and loss of hearing in left ear for 48 hours (treated with antibiotic)
J&J Dose 4/2/21 (1808978) COVID Positive 1/13/22  1/13/22: The patient is a 58-year-old male with a history of the aforementioned symptoms.  I am able obtain the history from the medical record as well as his wife at the bedside.  The patient had been drinking earlier this evening.  He fell directly on the ice, he tried to get up and crawled home.  He called the Emergency Medical Services. It was noted that he had significant bleeding from an open fracture, which was on his left lower extremity.  He was brought to the emergency room.  He has a history of alcohol use and Orthopedics was consulted for management and treatment.  1/16/22: Patient is a 58-year-old male who presents to the emergency room after slipping and falling on the ice. Patient was noted with a left ankle, fibula and tibia which required open reduction and internal fixation(ORIF). Orthopedic was consulted patient underwent ORIF with Dr. 01/14/202. Pulse operatively patient was noted with hypoxia requiring supplemental oxygen. Patient tested positive for COVID-19 on December 15, 2021 and states that he also was vaccinated with the Johnson and Johnson vaccine. Repeat test during this admission came back positive the patient does not have any signs of infection. Chest x-ray came back negative and patient was able to wean off supplemental oxygen. He was able to maintain his sats above 90% on room at rest and with activities. He worked with PT recommended home physical therapy. RN care coordination referred patient to a home care service. Patient will need 325 mg p.o. b.i.d. for 4 weeks for VTE prophylactic per ortho. Patient to follow-up with Dr. in 1 week at the clinic and continue on strict non-weight-bearing.  He was provided with crutches and will be discharging home this evening. Pain medication, aspirin  e-prescribed patient is aware. Today patient has stable vital signs he was seen and evaluated at bedsides. All questions answered patient updated on test findings.
Hospitalized for acute altered mental status that occured approix 6 hours after getting high dose influenza vaccine, extensive work-up was done including CXR, CT head, MRI brain and carotid ultrasound all negative for acute findings.  Discharge disagnosis: post influenza vaccine encephalopathy.
About a week after the shot I started to get a rash on my shoulder which spread to my chest and then the back of my head/neck. The rash was itchy and then within a few days turned to blisters/scabbing. I went to urgent care and was diagnosed with Shingles. I received medication and took that for 7 days.
Body aches, joint pain, headache, low-grade fever. Symptoms lasted approximately 30 hours.
Sore left arm; Pain at the injection site; The patient received a fourth dose/ Pharmacist told the patient  that he was receiving a full 0.5ml dose /Pharmacist then proceeded to administer the 0.5ml dose instead of the 0.25ml dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), VACCINATION SITE PAIN (Pain at the injection site) and EXTRA DOSE ADMINISTERED (The patient received a fourth dose/ Pharmacist told the patient  that he was receiving a full 0.5ml dose /Pharmacist then proceeded to administer the 0.5ml dose instead of the 0.25ml dose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L21B, 011D21A, 016M20A and 029o20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 28-Jan-2022, the patient experienced PAIN IN EXTREMITY (Sore left arm) and EXTRA DOSE ADMINISTERED (The patient received a fourth dose/ Pharmacist told the patient  that he was receiving a full 0.5ml dose /Pharmacist then proceeded to administer the 0.5ml dose instead of the 0.25ml dose). 28-Jan-2022, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 28-Jan-2022, EXTRA DOSE ADMINISTERED (The patient received a fourth dose/ Pharmacist told the patient  that he was receiving a full 0.5ml dose /Pharmacist then proceeded to administer the 0.5ml dose instead of the 0.25ml dose) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore left arm) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.  The patient wanted to receive a booster dose of the Moderna Covid-19 vaccine. The Pharmacist told the patient that he was receiving a full 0.5ml dose. The Pharmacist then proceeded to administer the 0.5ml dose instead of the 0.25ml dose.   This case was linked to MOD-2022-465694, MOD-2022-465769, MOD-2022-465795 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2022: Follow-up received. Reporter Contact details updated. On 28-Jan-2022: Follow-up received contains No new information.